簡要描述:
Lec1(卵巢細(xì)胞)?本公司長期經(jīng)營、抗體、細(xì)胞因子、生化試劑、實(shí)驗(yàn)耗材、儀器等生物化學(xué)試劑產(chǎn)品。主營各類進(jìn)口國產(chǎn)優(yōu)質(zhì)細(xì)胞,誠信經(jīng)營,價(jià)格實(shí)惠,服務(wù)周到,質(zhì)量有保證。詳細(xì)情況請咨詢銷售人員。
更新時(shí)間:2021-06-09;廠商性質(zhì):經(jīng)銷商;覽量:635
Lec1(卵巢細(xì)胞)
ATCC
Applications: transfection host (Roche FuGENE® Transfection Reagents)
Gender: female
Comments: This line is a mutant clone derived from the parental CHO clone Pro-5 (a proline auxotroph, see ATCC CRL-1781) by selection for resistance to wheat germ agglutinin. The cells lack GlcNAc glycosyl transferase so that N-linked carbohydrates are blocked at the Man5-GlcNAC2-Asn intermediate. The line may be useful for studying the effects of altered N-linked glycosylation on the
細(xì)胞(Cell):能進(jìn)行獨(dú)立繁殖的有膜包圍的生物體的基本結(jié)構(gòu)和功能單位。一般由質(zhì)膜、細(xì)胞質(zhì)和(或擬核)構(gòu)成,是生命活動的基本單位。
本公司 誠信經(jīng)營生物化學(xué)試劑產(chǎn)品,價(jià)格實(shí)惠,服務(wù)周到,質(zhì)量有保證
Lec1(卵巢細(xì)胞) 其它相關(guān)產(chǎn)品:
293T/17 [HEK 293T/17] (人胚腎細(xì)胞) ATCC 株
AAV-293( 胚腎細(xì)胞 ) ATCC 株
hFOB 1.19(SV40 轉(zhuǎn)染成骨細(xì)胞) ATCC 株
CCD-1095Sk(皮膚細(xì)胞 ) ATCC 株
Hs 578Bst(乳腺細(xì)胞) ATCC 株
NK-92(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞) ATCC 株
NK-92MI(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞) ATCC 株
HMy2.CIR(人B 淋巴母細(xì)胞) ATCC 株
OK(負(fù)鼠(opossum)腎細(xì)胞) ATCC 株
FO(骨髓瘤細(xì)胞) ATCC 株
RAW 264.7(單核巨噬細(xì)胞白血?。?nbsp; ATCC 株
P19(畸胎癌細(xì)胞) ATCC 株
C6(膠質(zhì)瘤細(xì)胞) ATCC 株
RBL-2H3(白血病細(xì)胞) ATCC 株
SiHa(子宮頸癌細(xì)胞) ATCC 株
MG-63(骨肉瘤細(xì)胞) ATCC 株
HEC-1-B(子宮內(nèi)膜腺癌細(xì)胞) ATCC 株
SW1353(骨肉瘤細(xì)胞) ATCC 株
ES-2(卵巢透明細(xì)胞癌細(xì)胞) ATCC 株
Saos-2(成骨肉瘤細(xì)胞) ATCC 株
MDA-MB-468(乳腺癌細(xì)胞) ATCC 株
SK-MES-1(肺鱗癌細(xì)胞) ATCC 株
Lec1(卵巢細(xì)胞) 供應(yīng)商